Characteristics and main results of the included studies.
| Reference | Author/Year | Database | Study objective | Summary of results |
|---|---|---|---|---|
| [27] | Asouri et al./2020 | Web of Science | Genotyping of 14 SNPs in HLA-DRA and 14 SNPs in IL2RA by NGS in 102 Iranian MS patients | No significant association found between the SNPs and MS |
| [28] | Chi et al./2019 | PubMed | Genetic mapping and ancestry analysis of HLA alleles in African American, Hispanic, and Asian populations | Differences in MS risk were detected depending on HLA allele ancestry. European alleles DRB1*15:01, HLA-B*07:02, and HLA-A*03:01 conferred higher MS risk than their African counterparts |
| [29] | Fguirouche et al./2025 | Web of Science | Genotyping of HLA-A, -B, -DR, -DQ in healthy individuals from southern Morocco | Predisposing alleles identified: DRB1*03, *13, *15. No differences found between HLA class I alleles and MS susceptibility. Further studies in MS patients are needed |
| [30] | Khdair et al./2025 | Web of Science | Genotyping of HLA-DRB1 and HLA-DQB1 in MS patients from Jordan | Significant associations found between HLA alleles and MS susceptibility: DRB1*03:01 and DRB1*04:01 |
| [31] | Beecham et al./2022 | PubMed | Analysis of genetic risk modified by ancestry in HLA haplotypes in a multiethnic population | SNPs rs2844503, rs3021302, and rs760145 showed effects modified by global/local ancestry. HLA-A*02:01 had a stronger protective effect when of European origin, and HLA-B*53:01 conferred protection when inherited from African origin, especially among Hispanics |
| [32] | Goodin et al./2021 | PubMed | Analysis of full HLA haplotypes in African Americans with MS | The extended haplotype DRB1*15:01~DQB1*06:02 was most strongly associated with MS. The DRB1*15:03~DQB1*06:02 haplotype had a less consistent association depending on the specific haplotype |
| [33] | Osoegawa et al./2021 | PubMed | NGS genotyping of 11 HLA genes in families with MS | Association found between the haplotype DRB5*01:01~DRB1*15:01 and the allele DPB1*104:01 with MS. Alleles such as DRB1*01:01 and DQB1*03:01 showed a protective effect |
| [34] | Akel et al./2022 | PubMed | High-resolution HLA class II sequencing in Swedish MS patients | 69 distinct genotypes detected; extended haplotypes such as DRB5*01:01~DRB1*15:01-DQB1*06:02 were more frequent; protective and risk effects depended on specific combinations |
| [35] | Briggs and Sept/2021 | Web of Science | Identification of genetic association patterns in MS patient data | Combinations of variants such as HLA-DRB1*15:01, SNP rs56678847, and rs6880809 conferred a 20.2-fold increased risk of developing MS. Computational methods identified complex susceptibility patterns |
| [36] | Hedström et al./2021 | PubMed | Investigation of gene-environment interaction (HLA and factors such as smoking, EBV, obesity) | DRB1*15:01 allele increased the risk of developing MS additively, and the absence of A*02:01 increased the risk fivefold |
| [40] | Boullerne et al./2024 | PubMed | Validation of tagging SNPs for HLA risk alleles in MS using the 1000 genomes panel | SNPs with high performance for inference of DRB1*15:01, DQB1*06:02, and A*02:01 were identified across multiple populations |
| [37] | Barnes et al./2021 | PubMed | Analysis of common genetic variants in MS in Orkney and Shetland populations | SNP rs9271069 was more frequent in the islands than on the mainland and partly explained the excess MS cases |
| [38] | Gontika et al./2020 | Web of Science | Genotyping HLA-DRB1 in POMS and AOMS patients | HLA-DRB1*03 allele was significantly higher in the POMS group than in the AOMS group. In the POMS group, DRB1*11, *15, *03, *04, and *16 were identified as predisposing |
| [39] | Derdelinckx et al./2020 | PubMed | Analysis of myelin antigen reactivity in MS patients with different HLA class II genotypes | No correlation found between HLA class II genotype and myelin peptide reactivity |
| [41] | Mack et al./2019 | PubMed | Genotyping of HLA class I and II by NGS and analysis of KIR loci and their ligands | Association of DRB1*15:01 with MS was confirmed. Protective haplotypes identified: C*03:04~B*40:01; A*02:01 |
| [42] | Creary et al./2019 | Web of Science | High-resolution sequencing of DRB1*15:01 and DRB1*04:01 haplotypes in North Americans | Confirmation of DRB1*15:01~DRB5*01:01 haplotype in MS susceptibility; DRB1*04:01 had haplotype-dependent effects |
| [43] | da Silva Bernardes et al./2019 | PubMed | Genotyping of HLA-DR15 in familial MS cases in Brazil | Extended HLA-DR15 haplotype was found in 44% of familial cases and in none of the healthy controls |
| [44] | Asouri et al./2020 | Web of Science | Genotyping of 36 SNPs located in HLA-DRA, IL2RA, and HMGB1 genes using PCR and NGS | SNPs rs4935356, rs3177928, and rs7197 were considered predisposed to MS |
| [45] | Watanabe et al./2021 | Web of Science | Genotype-phenotype correlation with HLA-DRB1/DPB1 alleles in MS | DRB1*15:01 was associated with susceptibility and worse prognosis in MS; DRB1*04:05 with earlier onset |
| [46] | Ogawa et al./2019 | PubMed | NGS genotyping of 16 HLA genes (classical and non-classical) in Japanese MS patients | DRB1*15:01, DRB1*04:05, B*15:01, and B*39:01 were independently associated with MS |
| [47] | Burnard et al./2022 | Web of Science | Application of penalized regression (elastic net) to identify HLA and NK SNP associations with MS | Variants overlooked by traditional GWAS were identified, such as SNP rs2844482 |
SNPs: single nucleotide polymorphisms; HLA: human leukocyte antigen; NGS: next-generation sequencing; MS: multiple sclerosis; EBV: Epstein-Barr virus; POMS: pediatric-onset MS (early-onset, pediatric and adolescent, MS accounts for approximately 3–5% of all MS cases); AOMS: adult-onset MS; PCR: polymerase chain reaction; NK: natural killer; GWAS: genome wide association studies.